Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.58892 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.59413 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.68632 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51868 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.60693 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.72311 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.12038 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.744 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.77799 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.65769 | 29 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.6691 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66446 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.88956 | 39 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67493 | 30 |